Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2004-12-30
2010-12-28
Sheikh, Humera N (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S465000, C424S466000
Reexamination Certificate
active
07858121
ABSTRACT:
Fentanyl-containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than known oral formulation and have advantages in terms of reduced cost and reduced side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa.
REFERENCES:
patent: 1262888 (1918-04-01), Westlake
patent: 1263888 (1918-04-01), Westlake
patent: 3131123 (1964-04-01), Masquelier
patent: 3577490 (1971-05-01), Welsh et al.
patent: 3888976 (1975-06-01), Mlkvy et al.
patent: 3961041 (1976-06-01), Nishimura et al.
patent: 3962417 (1976-06-01), Howell
patent: 3972995 (1976-08-01), Tsuk et al.
patent: 4147768 (1979-04-01), Shaffer et al.
patent: 4187286 (1980-02-01), Marcus
patent: 4289751 (1981-09-01), Windheuser
patent: 4443428 (1984-04-01), Oshlack et al.
patent: 4493848 (1985-01-01), LaHann et al.
patent: 4503031 (1985-03-01), Glassman
patent: 4599342 (1986-07-01), LaHann
patent: 4613497 (1986-09-01), Chaukin
patent: 4639368 (1987-01-01), Niazi et al.
patent: 4671953 (1987-06-01), Stanley et al.
patent: 4687662 (1987-08-01), Schobel
patent: 4689218 (1987-08-01), Gazzaniga et al.
patent: 4725427 (1988-02-01), Ashmead
patent: 4753792 (1988-06-01), Aberg
patent: 4756710 (1988-07-01), Bondi et al.
patent: 4853211 (1989-08-01), Kurobe et al.
patent: 4863737 (1989-09-01), Stanley et al.
patent: 4940588 (1990-07-01), Sparks
patent: 5002771 (1991-03-01), Purkaystha et al.
patent: 5028411 (1991-07-01), Callingham et al.
patent: 5053396 (1991-10-01), Blass
patent: 5055306 (1991-10-01), Barry et al.
patent: 5073374 (1991-12-01), McCarty
patent: 5102666 (1992-04-01), Acharya
patent: 5135752 (1992-08-01), Snipes
patent: 5178878 (1993-01-01), Wehling et al.
patent: 5223264 (1993-06-01), Wehling et al.
patent: 5314904 (1994-05-01), Egidio et al.
patent: 5387420 (1995-02-01), Mitchell et al.
patent: 5445827 (1995-08-01), Fritsch et al.
patent: 5458879 (1995-10-01), Singh et al.
patent: 5464632 (1995-11-01), Cousin et al.
patent: 5468504 (1995-11-01), Schaeffer
patent: 5501861 (1996-03-01), Makino et al.
patent: 5503846 (1996-04-01), Wehling et al.
patent: 5550861 (1996-08-01), Chan et al.
patent: 5559096 (1996-09-01), Edwards et al.
patent: 5607697 (1997-03-01), Alkire et al.
patent: 5624687 (1997-04-01), Yano et al.
patent: 5626866 (1997-05-01), Ebert et al.
patent: 5646151 (1997-07-01), Kruse et al.
patent: 5656284 (1997-08-01), Balkin
patent: 5720974 (1998-02-01), Makino
patent: 5785989 (1998-07-01), Stanley et al.
patent: 5807688 (1998-09-01), Blackburn et al.
patent: 5853748 (1998-12-01), New
patent: 5900252 (1999-05-01), Calanchi et al.
patent: 5952004 (1999-09-01), Rudnic et al.
patent: 5958455 (1999-09-01), Roser et al.
patent: 5958458 (1999-09-01), Norling et al.
patent: 6034085 (2000-03-01), Joshi et al.
patent: 6068853 (2000-05-01), Giannos et al.
patent: 6071539 (2000-06-01), Robinson et al.
patent: 6106861 (2000-08-01), Cheveau
patent: 6117912 (2000-09-01), DiSanto
patent: 6129906 (2000-10-01), Steventon
patent: 6155423 (2000-12-01), Katzner et al.
patent: 6200604 (2001-03-01), Pather et al.
patent: 6242002 (2001-06-01), Tritthart et al.
patent: 6264981 (2001-07-01), Zhang et al.
patent: 6316027 (2001-11-01), Clarke et al.
patent: 6326360 (2001-12-01), Kanazawa et al.
patent: 6326384 (2001-12-01), Whittle et al.
patent: 6350470 (2002-02-01), Pather et al.
patent: 6368625 (2002-04-01), Siebert et al.
patent: 6391335 (2002-05-01), Pather et al.
patent: 6488961 (2002-12-01), Robinson et al.
patent: 6509036 (2003-01-01), Pather et al.
patent: 6576250 (2003-06-01), Pather et al.
patent: 6641838 (2003-11-01), Pather et al.
patent: 6680071 (2004-01-01), Johnson et al.
patent: 6759059 (2004-07-01), Petterson et al.
patent: 6761910 (2004-07-01), Petterson et al.
patent: 6764696 (2004-07-01), Pather et al.
patent: 6974590 (2005-12-01), Pather et al.
patent: 2001/0006677 (2001-07-01), McGinity et al.
patent: 2002/0160991 (2002-10-01), Shao
patent: 2004/0213855 (2004-10-01), Petterson et al.
patent: 2005/0037072 (2005-02-01), Pather et al.
patent: 2005/0142197 (2005-06-01), Moe et al.
patent: 2005/0163838 (2005-07-01), Moe
patent: 2005/0169989 (2005-08-01), Moe et al.
patent: 2006/0292219 (2006-12-01), Pather et al.
patent: 2007/0036853 (2007-02-01), Agarwal et al.
patent: 2211586 (1996-08-01), None
patent: 2254060 (1997-01-01), None
patent: 2218370 (1997-02-01), None
patent: 0 197 504 (1986-10-01), None
patent: 0 354 973 (1990-02-01), None
patent: 0361680 (1990-04-01), None
patent: 1 062 952 (2000-12-01), None
patent: 3160 (1872-10-01), None
patent: 2307857 (1997-06-01), None
patent: 7-277959 (1995-10-01), None
patent: 36236 (1981-04-01), None
patent: 40484 (1981-12-01), None
patent: 200611697 (2006-04-01), None
patent: WO-91/04757 (1991-04-01), None
patent: 95/07701 (1995-03-01), None
patent: WO-95/27482 (1995-10-01), None
patent: WO-95/34291 (1995-12-01), None
patent: WO-96/29993 (1996-10-01), None
patent: WO-97/17067 (1997-05-01), None
patent: WO-99/45934 (1999-09-01), None
patent: WO-99/49842 (1999-10-01), None
patent: WO-00/09093 (2000-02-01), None
patent: WO-00/35418 (2000-06-01), None
patent: 00/59423 (2000-10-01), None
patent: WO-2004/067004 (2004-08-01), None
Stanley et al, “Novel Delivery Systems: Oral Transmucosal and Intranasal Transmucosal”, Journal of Pain and Sympton Management, vol. 7, No. 3, Apr. 1992, pp. 163-171.
Weinberg et al., “Sublingual absorption of selected opioid analgesics”, Clinical Pharmacology and Therapeutics, Sep. 1988, 44 (3), pp. 335-342.
Streisand et al., “Buccal absorption of fentanyl is pH-dependent in dogs”, Anesthesiology, (Mar. 1995), 82 (3), pp. 759-764.
Chen et al., “Studies on formulations of fentanyl buccal adhesive tablets”, Zhonggup Yiyao Gongye Zazhi, 1997, 28 (3), 129-131.
Supplementary European Search Report, EP 00 92 6341, Dated Nov. 23, 2005.
Audus, K., et al, “The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies”, Pharmaceutical Research, vol. 7, No. 5, 1990, p. 435.
U.S. Appl. No. 09/661,693, filed Sep. 14, 2000.
Hessel, P.G., et al., “A Comparison of the availability of prochlorperazinc following i.m. buccal and oral administration”, International Journal of Pharmaceutics, Jun. 1, 1989, vol. 52, Issue 2, p. 159-164.
Pather et al.,“Buccal Delivery—Enhanced Buccal Delivery of Fentanyl Using the Oravescent Drug Delivery System”, Drug Delivery Tech. , vol. 1, No. 1, Oct. 2001.
James W. Conine, Special Tablets, in Pharmaceutical Dosage Forms: Tablets vol. 1, 329 (Herbert A. Lieberman et al. eds, 1989).
Alternative Routes of Drug Administration—Advantages and Disadvantages (Subject Review), American Academy of Pediatrics Committee on Drugs, Pediatrics, vol. 100, No. 1 Jul. 1997, 143, 147.
Ranade, V.V.; Drug Delivery Systems Part 5B. Oral Drug Delivery, The Journal of Clinical Pharmacology, Feb. 1991, pp. 98-115, vol. 31.
Giannos, S.A.; Dinh, S.M.; Berner, B.; Temporally Controlled Drug Delivery Systems: Coupling of pH Oscillators with Membrane Diffusion, Journal of Pharmaceutical Sciences, May 1995, pp. 539-543, vol. 84, No. 5.
Amighi, K.; Timmermans, J.; Puigdevall, J.; Baltes, E.; Moës, A.. J.; Peroral Sustained-Release Film-Coated Pellets as a Means to Overcome Physicochemical and Biological Drug-Related Problems. I. In Vitro Development and Evaluation, Drug Development and Industrial Pharmacy, 1998, pp. 509-515, vol. 24, No. 6.
Sorasuchart, W.; Wardrop, J.; Ayers, J.; Drug Release from Spray Layered and Coated Drug-Containing Beads: Effects of pH and Comparison of Different Dissolution Methods, Drug Development and Industrial Pharmacy, 1999, pp. 1093-1098, vol. 25, No. 10.
Berko, S.; Regdon Jun, G.; Erös, I.; Influence of pH Change on Drug Release from Rectal Suppositories, Die Pharmazie, Apr. 2000, p. 324, vol. 55., Govi-Verlag Pharmazeutischer Verlag GmbH, Eschborn.
Streubel, A.; Siepmann, J.; Dashevsky, A.; Bodmeier, R.; pH-Independent Release of a Weakly Basic Drug from Water-Insoluble and -Soluble Ma
Agarwal Vikas
Habib Walid
Moe Derek
Cima Labs Inc.
Sheikh Humera N
LandOfFree
Effervescent oral fentanyl dosage form and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Effervescent oral fentanyl dosage form and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effervescent oral fentanyl dosage form and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4198283